Sign in to continue:

Saturday, May 2nd, 2026

OFS Capital Corp 2026 Q1 10-Q: Portfolio Investments, SOFR-Based Debt, and Affiliate Transactions Overview

OFS Capital Corp Q1 2026 Financial Report: Key Insights for Investors

OFS Capital Corp Q1 2026 Financial Report: Key Insights for Investors

Overview

OFS Capital Corp (NASDAQ: OFS), a leading business development company focused on lending to U.S. middle-market companies, has released its 10-Q report for the quarter ended March 31, 2026. The report details the company’s financial performance, portfolio composition, investment activity, and debt profile. Below, we break down the key takeaways and highlight critical points that shareholders and investors should closely monitor.

Key Highlights

  • Broad Exposure to Variable Interest Rate Investments: OFS Capital’s portfolio continues to be heavily weighted toward variable rate instruments, with a significant majority of investments linked to the Secured Overnight Financing Rate (SOFR). This positions the company to benefit from rising interest rates, as higher rates can positively impact investment income.
  • Diversified Portfolio Composition: The company’s investments span a wide range of industries, including software, pharmaceuticals, property management, health care, and structured finance securities. Notably, the portfolio includes significant investments in first lien and second lien debt, preferred stock, common equity, and structured finance subordinated notes.
  • New and Follow-On Investments: The filing reveals new and follow-on investments across multiple portfolio companies, including recent acquisitions in affiliate and non-affiliate investments, such as Pfanstiehl Holdings, Inc. (pharmaceuticals), Redstone Holdco 2 LP (software and computer peripherals), PSB Group, LLC (intangible asset lessors), and Excelin Home Health, LLC (home health care), among others.
  • Significant Interest Rate Spreads: Many of OFS Capital’s new investments carry substantial spreads above SOFR, with some first lien debt assets offering spreads of 6.25% to 8.50% above SOFR, and several structured finance notes yielding interest rates above 10% or even 20%. These high-yield assets drive strong income but may also be associated with higher credit risk.
  • Focus on Senior Secured Debt: The portfolio continues to emphasize first lien senior secured debt, which provides greater protection in downside scenarios. Several large positions are in first lien loans to companies in industries like property management, software, and business services.
  • Active Participation in Structured Finance: OFS Capital holds numerous subordinated notes and mezzanine debt positions in CLOs (Collateralized Loan Obligations) and other structured finance vehicles. These positions often have high stated interest rates, reflecting both the income potential and the underlying risks.
  • Ongoing Debt Issuance and Refinancing: The company maintains various unsecured notes with staggered maturities between 2026 and 2029. The fair value hierarchy disclosures indicate that these liabilities are valued using Level 3 inputs, suggesting a reliance on unobservable market data.
  • Use of Multiple Valuation Techniques: Investments are valued using a mix of market approach (EBITDA/revenue multiples) and discounted cash flow techniques. The report shows that a significant portion of the portfolio is classified as Level 3 under the fair value hierarchy, indicating limited marketability and higher subjectivity in valuation.

Potentially Price-Sensitive Information for Shareholders

  • Interest Rate Sensitivity: With the majority of investments tied to SOFR and high spreads, OFS Capital is highly sensitive to changes in interest rates. Any shifts in the rate environment can materially impact investment income and net investment returns.
  • Concentration Risks: The document shows notable concentrations in certain counterparties and advisers, as well as in specific industries like software, health care, and structured finance. Any adverse developments in these areas could have an outsized impact on NAV and share price.
  • Credit Quality and Default Rates: The company’s pursuit of high-yield assets, particularly in structured finance, means that credit risk is elevated. Investors should be aware that a downturn in credit markets or higher than expected default rates could negatively affect portfolio valuations and dividend coverage.
  • New Investment Activity: The addition of large new positions, especially in affiliate transactions and new sectors, may alter the risk/reward profile of the portfolio. Notable new investments highlighted in the filing include:
    • First lien debt in PSB Group, LLC and Metasource, LLC (both with SOFR+6.75% and SOFR+6.25% spreads, respectively).
    • Affiliate equity investments in Pfanstiehl Holdings, Inc. and Contract Datascan Holdings, Inc.
    • Structured finance purchases such as the Apex Credit CLO series, Battalion CLO XI Ltd., and CBAMR 2017-1, Ltd., all with double-digit interest rates.
    • Follow-on investments in Redstone Holdco 2 LP (SOFR+5.50% spread), which could indicate confidence in the borrower but also concentration risk.
  • Dividend Policy and Earnings: The presence of high-yielding investments and the company’s ability to generate sufficient net investment income to cover dividends is crucial. Any changes in the ability to maintain distributions could be price moving.
  • Potential Fair Value Adjustments: Given the use of Level 3 inputs and the market approach, significant changes in market multiples or cash flow projections (due to macroeconomic or company-specific factors) could lead to substantial fair value adjustments and impact the NAV per share.
  • Exposure to Affiliate Transactions: The report details numerous affiliate investments and related party transactions, especially with Contract Datascan Holdings, Inc. and Pfanstiehl Holdings, Inc. Investors should be aware of potential conflicts of interest, which may attract regulatory or shareholder scrutiny.
  • Debt Maturities and Refinancing Risk: With several tranches of unsecured notes coming due between 2026 and 2029, the company faces refinancing risk, particularly if market conditions tighten or if its credit profile deteriorates.

Detailed Portfolio Developments

  • New Debt Investments: OFS Capital originated new first lien and second lien loans with attractive yields, including:
    • Metasource, LLC: First Lien Debt, 10.18% cash / 0.50% PIK, SOFR+6.25%, maturing 9/30/2029.
    • PSB Group, LLC: First Lien Debt, 10.47%, SOFR+6.75%, maturing 4/17/2030.
    • Excelin Home Health, LLC: Second Lien Debt, 18% PIK, maturing 10/1/2029.
    • Redstone Holdco 2 LP: First Lien Debt, 10.56%, SOFR+6.75%, maturing 3/2/2029.
  • Structured Finance and CLOs: Several new and existing investments in CLO subordinated notes and mezzanine tranches, such as:
    • CBAMR 2017-1, Ltd.: Subordinated Notes, 21.02% interest, maturing 1/20/2038.
    • ICG US CLO 2021-3, Ltd.: Subordinated Notes, 26.57% interest, maturing 10/20/2034.
    • Battalion CLO XI Ltd.: Mezzanine Debt, SOFR+6.85% spread, maturing 4/24/2034.
    • LCM 42 Ltd.: Subordinated Notes, 18.54% interest, maturing 1/15/2038.
  • Affiliate Equity and Preferred Stock:
    • Pfanstiehl Holdings, Inc.: Common Equity (Class A), pharmaceutical manufacturing, initial acquisition in 2014 with continued holdings.
    • Contract Datascan Holdings, Inc.: Preferred Equity (Series A and C shares), 10% and 14% PIK, respectively, in office machinery rental/leasing.
  • Debt and Equity in Non-Affiliate Companies:
    • Honor HN Buyer Inc.: First Lien Debt (Delayed Draw), SOFR+5.75% spread, maturing 10/15/2027.
    • RPLF Holdings, LLC: Common Equity (software publishers), ongoing position.
    • Tolemar Acquisition, Inc.: First Lien Debt (Revolver), office machinery rental.
  • Credit Facilities and Revolvers: OFS maintains multiple credit lines, including facilities from Natixis and Banc of California, which are subject to interest rate changes and refinancing terms.
  • Geographic and Industry Diversification: The portfolio covers a range of industries, with significant exposure to software, pharmaceutical, property management, health care, and structured finance.

Conclusion: Investor Considerations

The Q1 2026 report from OFS Capital Corp demonstrates a strategy focused on high-yield, variable rate investments with an emphasis on first lien debt and structured finance. While this strategy can deliver robust income in a rising rate environment, it also introduces increased credit and market risk, especially given the large proportion of Level 3 assets. Investors should closely monitor the company’s ability to manage credit quality, maintain dividend coverage, and navigate refinancing risks in its debt structure.

Shareholders should also be aware of the potential for fair value adjustments in the portfolio, concentration risks, and the implications of affiliate transactions. Any adverse developments in these areas could have a material impact on share price and NAV. Conversely, continued favorable rate trends and credit performance could be a catalyst for positive share price movement.


Disclaimer: This article is for informational purposes only and does not constitute investment advice. Investors should review the full 10-Q filing and consult with their financial advisors before making any investment decisions. Financial markets are subject to risks, including loss of principal.


View OFS Capital Corp Historical chart here



TG Therapeutics, Inc. (TGTX) Enters $750 Million Term Loan Agreement – SEC 8-K Filing Summary

Overview On March 18, 2026, TG Therapeutics, Inc. (“TG Th...

FS KKR Capital Corp Files Form 8-K: Company Details, Address, and Common Stock Listing on NYSE

FS KKR Capital Corp. Files Regulation FD Disclosure Via Form...

   Ad

Join Our Investing Seminar

Limited seats available — Reserve your spot today